Lotus Eye Hospital and Institute Limited

NSEI:LOTUSEYE 주식 보고서

시가총액: ₹1.2b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Lotus Eye Hospital and Institute 대차 대조표 상태

재무 상태 기준 확인 6/6

Lotus Eye Hospital and Institute 의 총 주주 지분은 ₹594.1M 이고 총 부채는 ₹0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 ₹666.3M 및 ₹72.2M 입니다. Lotus Eye Hospital and Institute 의 EBIT는 ₹28.0M 이며 이자보상배율은 28.8 입니다. ₹70.4M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

0%

부채 비율

₹0

부채

이자 보상 비율28.8x
현금₹70.40m
주식₹594.09m
총 부채₹72.18m
총 자산₹666.27m

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Jan 24
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 08
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Jul 15
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

Apr 07
Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Oct 08
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 02
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

Jun 17
If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Mar 11
MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Dec 30
Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

Nov 20
Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Sep 21
The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Aug 27
Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Aug 03
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

Jul 06
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

재무 상태 분석

단기부채: LOTUSEYE 의 단기 자산 ( ₹140.2M )이 단기 부채( ₹62.3M ).

장기 부채: LOTUSEYE 의 단기 자산( ₹140.2M )이 장기 부채( ₹9.9M ).

부채 대 자본 내역 및 분석

부채 수준: LOTUSEYE 부채가 없습니다.

부채 감소: LOTUSEYE 는) 부채 대 자기자본 비율이 0.2% 였던 5년 전과 비교하여 부채가 없습니다.

부채 범위: LOTUSEYE 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: LOTUSEYE 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

대차 대조표

건강한 기업 발견하기

7D

1Y

7D

1Y

7D

1Y